Study of RNS60 on Pain and Function After Hip Labral Repair
Sponsor
Revalesio Corporation (Industry)
Overall Status
Withdrawn
CT.gov ID
NCT02005523
Collaborator
(none)
0
1
2
Study Details
Study Description
Brief Summary
The purpose of this study is to see if use of RNS60 during hip labral repair surgery decreases pain and improves functional capacity post-operation.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
Phase 2 |
Study Design
Study Type:
Interventional
Actual Enrollment
:
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Treatment
Official Title:
Study of RNS60 on Post-operative Pain and Function in Patients Undergoing Hip Labral Repair or Reconstruction Surgery
Actual Primary Completion Date
:
Oct 1, 2014
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: RNS60
|
Drug: RNS60
|
Placebo Comparator: Saline
|
Drug: Saline
|
Outcome Measures
Primary Outcome Measures
- Assessment of post-operative pain [1 week]
Comparison of scores from validated pain scales from post-surgery to one week.
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Tacoma | Washington | United States |
Sponsors and Collaborators
- Revalesio Corporation
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Revalesio Corporation
ClinicalTrials.gov Identifier:
NCT02005523
Other Study ID Numbers:
- 07.1.1.H2
First Posted:
Dec 9, 2013
Last Update Posted:
Feb 6, 2015
Last Verified:
Feb 1, 2015
Additional relevant MeSH terms: